on behalf of all share holders and i, thank you for your (quick)...

First 6 Last

Share
Profile

Follow
Cylon

121 Posts.

3

12/12/23

17:03

Post #: 71409826
Share

Originally posted by AusCannOfficial: ↑

I can't speak to the past board members salaries from inception but at the moment the salary pool for the 3 board members totals $170k all up so certainly not $500k each...over the last little while we have cut all costs and attempted to put the company in a position that it is pretty much cash flow neutral.

Neuvis - the original AC8 Management team spent a lot of time and money trying to get a product to market as a delivery system for medical cannabis. Unfortunately they were doing this before there was an actual market and without actual knowledge of what the market looked like - AC8 isn't on their own in this regard as the MC market as we know it has changed and morphed almost on a monthly basis since it was first introduced in 2018. To give you an idea other companies in the sector built facilities to cater for 75 tn of product per annum only to realise 5 years later that the overall market in Oz for Medical product is maximum - 25 tn per annum. What I don't think anyone in the industry foresaw was that circa 75% of Medical Cannabis users are actually Recreational users just accessing better quality product...there is a reason why 75% of sales of Medical Cannabis in Oz (and around the world for that matter) is flower when arguably the best way to access pure Medical product, is via an extract...Unfortunately with every start up business and start up industry, there are twists and turns and money is sometimes not spent in the right areas. At the time, the board and management did what they thought was best with the information they had at the time. Only with hindsight has it proven to be incorrect. We are currently looking at options to sell Neuvis but do not have a suitable solution at this time.

CannPal - a good little company but scale was an issue and it needed a lot more money spent on it that the AC8 board decided wasn't in the best interests of shareholders. Again the regulatory pathway for CannPal changed and the AC8 board made the strategic decision that spending the companies money in an area that the market wasn't rewarding, was a pointless exercise so we have maintained a carried interest of 48% of the equity in CannPal while Layton pursues commercial funding partners for its development. We are confident Layton will achieve his goal with it and AC8 will have an uplift in time on the balance sheet, as a result.

As soon as we have more information on the future direction of AC8 we will communicate this - but I can tell you all - it won't be long from here.

Expand

on behalf of all share holders and i, thank you for your (quick) response, it feels like a cool breeze on the face on a hot day, yer.

soo,, am i anywhere near to an understanding that, that the neuvis product resulted from the SEED research, which i believe, ended in failure by previous company, then taken up by ac8? did ac8 bm's realize this product to be a dog (no disrespect to real dogs) and soo bought into canpal?

just a question that you may find stupid but... do all on ac8 payroll work full time for this company and, again i show my ignorance, is there a place to validate.
cheers
just luuuve your response time;.

AC8 Price at posting: 4.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

TYX

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

First 6 Last

Add AC8 (ASX) to my watchlist

on behalf of all share holders and i, thank you for your (quick)...

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Featured News